Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients. A Multi-center, Observational Trial.

NCT05866302 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT05866302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients. A Multi-center, Observational Trial.
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
May 30, 2023
Completion date
May 31, 2028
Enrollment
375 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lung disease, graft versus host disease, hematopoietic cell transplantation